JW Therapeutics IPO: Valuation Insights
The core drug candidate’s competitive advantage in the China CAR-T market, a good cornerstone investor lineup and our valuation analysis suggest...
444 Views
Insights On China Healthcare Policy - 4+7: New Volume-Based Purchasing Policy
This article analyzed China’s revolutionary volume-based purchasing policy, its impact on domestic healthcare companies and related investment...
436 Views
JW Therapeutics IPO Initiation: Potent Medicine
JW’s core drug candidate’s competitive advantage is supported by its potential best-in-class safety profile with competitive efficacy, physicians’...
370 Views
Quiddity Weekly H/A: Share Spread Monitor 16 Oct 2020
Weekly Monitor for H-Share/A-Share spreads showing spread/discount performance, spread Z-scores, southbound buying and selling and net activity...
409 Views
Asia Short Interest Weekly: AliHealth, Meituan, SunnyOptical, WuXi Apptec, Canon, Lasertec, Seegene
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
294 Views